Baylor College of Medicine receives sizable grant from Komen for cancer research

Baylor researchers received nearly $1 million in grant funding to advance breast cancer research.

Researchers from Baylor College of Medicine in Houston received $960,000 from Susan G. Komen for the Cure to advance breast cancer research.

Dr. Sao Jiralerspong, assistant professor in the Lester and Sue Breast Center at BCM, was awarded a $450,000 grant to explore the lab potential of metformin, a diabetes drug, to reduce the threat that ductal carcinoma in situ will spread and develop into a more invasive type of cancer.

Dr. Melissa Bondy, professor of pediatrics in hematology and oncology, received $225,000 in funding to test a new method for assessing breast cancer risk using copy number variation, or structural changes in the genome that result in deletion of genes, deletion of parts of them or extra copies of them.

Bondy will look at classifying risk into multiple groups.

Dr. Jeffrey Rosen, the C.C. Bell Professor of Molecular and Cellular Biology at BCM, received $225,000 to study the function of a tumor-suppressing gene in mammary gland development and breast cancer.

Dr. Bert O'Malley, professor and chair of molecular and cellular biology at BCM, was awarded $62,500 to study a particular protein's potential role in the progression of ductal carcinoma in situ from a non-invasive to invasive cancer.

Bayan Raji covers health care for the Houston Business Journal. For her breaking stories and industry insights, follow her on Twitter.

Source: http://feedproxy.google.com/~r/vertical_13/~3/HLi4mJNS_Fk/baylor-receives-sizable-grant-from.html

facebook organ donor jessica simpson gives birth carrie underwood blown away chk ryan seacrest beltane ryan o neal